Unitree

company
humanoidhardware-platformzero-shotlocomotionchinaiposhipments

Company dossier

Unitree Robotics — the primary-source profile

Unitree

Type: Humanoid/Quadruped Robotics Company

Unitree manufactures the H1-2 and G1 humanoid robots that served as the primary test platforms for the Humanoid-COA (Chain of Action) framework. While Unitree is primarily a hardware manufacturer, their platforms have become important testbeds for academic robotics research due to their accessibility and capable hardware specifications.

The Humanoid-COA experiments on Unitree platforms demonstrated zero-shot loco-manipulation capabilities from natural language instructions — achieving 96.6% grasping accuracy and 90% mobile pick success rates. These results were achieved without any task-specific training on the Unitree hardware, validating the platforms as capable vehicles for foundation model-driven robot control.

The H1-2 (larger, more capable) and G1 (smaller, more agile) provide complementary form factors for testing different aspects of loco-manipulation, from heavy object manipulation to confined-space navigation.

By 2026 Unitree had become one of the two anchors of the Chinese humanoid volume market. TrendForce projects that Unitree and AgiBot together capture ~80% of Chinese humanoid shipments — and China produces the overwhelming majority of global units. Unitree has committed to 75,000 humanoid + 115,000 quadruped units of annual capacity, and reported ~5,500 humanoid units shipped in 2025 (per its IPO prospectus). On June 1, 2026 the Shanghai Stock Exchange listing committee cleared Unitree's IPO — the first "embodied AI" / humanoid pure-play approved for China's A-share market — targeting a ~$6.2B valuation and a ~$616M (4.2B yuan) raise. NVIDIA has also partnered with Unitree on humanoid robotics research ahead of the listing. Unitree's position illustrates the trans-Pacific split in the sector: Western programs (Tesla, Figure, Boston Dynamics) command the capital narrative, while Chinese programs lead on shipped volume and are now reaching the public markets first.

Key Contributions

  • H1-2 and G1 as CoA test platforms: Provided hardware for Humanoid-COA zero-shot loco-manipulation experiments achieving 96.6% grasping, 90% mobile pick (Humanoid-COA: Chain of Action)
  • Accessible humanoid hardware for research: Platforms adopted by academic researchers for foundation model and learning-based robotics experiments (Humanoid-COA: Chain of Action)
  • Chinese humanoid volume co-leader (~80% duopoly with AgiBot): 75K humanoid + 115K quadruped/yr capacity commitment; ~5,500 humanoids shipped 2025. Evidence: moderate (TrendForce)
  • First humanoid pure-play cleared for a China A-share IPO (Jun 1, 2026): ~$6.2B target valuation, ~$616M raise; first public-market test of humanoid investor appetite. Evidence: moderate (TrendForce context)

Mentioned In

Related Entities

  • Figure AI — Competing humanoid platform with integrated hardware/software approach
  • 1X Technologies — Competing humanoid platform targeting consumer market
  • AgiBot — The other anchor of the Chinese humanoid duopoly (~80% combined share)

Changelog

  • 2026-06-24 — Added Chinese-duopoly volume position (~80% with AgiBot), 75K/115K capacity commitment, 5,500 units shipped 2025, and the June 1 2026 Shanghai IPO clearance ($6.2B). Linked humanoid-market-landscape and new AgiBot entity.